IL1A and periodontitis: A previous study evaluating an extensive panel of GCF mediators, prior to and following initial therapy, in subjects with generalised severe chronic periodontitis, demonstrated that the total levels of numerous cytokines and chemokines, including IL-1α, -1β and -6, decreased significantly in disease sites in response to therapy (8).